associated with disease remission in patients with IBD, suggesting targeted dosing might be
anti-inflammatory. This study aimed to assess the effectiveness, safety and predictors of a 12-
week regimen of vitamin D supplementation to achieve such a target in patients with active
disease. Methods In a pilot study, patients with active colitis and a serum 25 (OH) D
concentration< 75 nmol/L were prescribed oral liquid vitamin D supplementation over 12 …